Phathom Pharmaceuticals, Inc.
Phathom Pharmaceuticals, Inc. (PHAT) is a publicly traded company in the Unknown sector. Across all available filings, 22 corporate insiders have executed 247 transactions totaling $158.4M, demonstrating a bearish sentiment with -$67.7M in net insider flow. The most recent transaction on Jan 21, 2026 involved a transaction of 776 shares valued at $10.6K.
PHAT Insider Activity Summary
Who Is Buying PHAT Stock?
No significant insider buying has been recorded for PHAT in the recent period.
Who Is Selling PHAT Stock?
No significant insider selling has been recorded for PHAT in the recent period.
Is Phathom Pharmaceuticals, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for PHAT is bearish with an Insider Alignment Score of 29/100 and a net flow of -$67.7M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
PHAT Frequently Asked Questions
Understanding PHAT Insider Activity
Insider trading at Phathom Pharmaceuticals, Inc. (PHAT) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 22 insiders are actively trading PHAT stock, having executed 247 transactions in the past 90 days. The most active insider is Pharmaceutical Co Ltd Takeda (Executive), who has made 53 transactions totaling $58.5M.
Related Tools
Track Phathom Pharmaceuticals, Inc. Insider Activity
Get notified when executives and directors at PHAT file new Form 4 transactions